Military Health System Research Symposium

Sense Neuro’s Technology Will Change the Treatment of Neurological Disorders

The effects of stroke and traumatic brain injury (TBI) touch every person. 15 million people suffer from strokes and more than 50 million people experience a TBI every single year. In the U.S. alone, up to 80,000 patients are misdiagnosed every year, potentially leading to permanent disability or death.

Our solution: a headset transmitting a low-power radio frequency through the entire cranial vault that detects TBI and stroke. This core technology is in three headsets to be used in three vastly different environments. We hope this will change the face of the treatment of neurological disorders as our technology evolves to detect and diagnose in real time.

Founder Dr. George Shaw is fighting for our non-invasive headsets to be utilized to the fullest extent so we can meet this tremendous, unmet medical need. “We’re going to be able to bring technology in the field, in the E.R., the ICU, the military, anywhere a stroke or traumatic brain injury will present itself,” Shaw says. “We will be able to detect a condition very quickly so that people are able to come in and get the kind of treatment they need as quickly as possible.”

Here are the places Sense Neuro’s technology will make a difference in the lives of those who suffer from stroke or TBI so far.

Emergency Rooms
Dr. Shaw says every trauma care facility needs NeuSTAT for continuous hospital monitoring. He sees neurological cases in the ER constantly. He adds, “This will improve your triage for the head-injured patient. It’ll reduce your time to diagnosis for intracranial hemorrhage, for any cranial hemorrhage. And it will reduce your time to treat or transfer those folks as well.”

ERs are notoriously busy and patients can spend a lot of time in the waiting room, sometimes for hours. Our devices are easy-to-use, accurate, and fast so that medical professionals don’t risk losing precious time when treating a neurological deficit.

Also, the device doesn’t just detect a hemorrhage. It can monitor the patient over time to see if a bleed expands. Instead of disconnecting the patient and moving them to get a CT scan after several hours, the NeuSTAT device can detect if their condition is worsening in real time.

If getting to the hospital via ambulance, EMTs making the decision at the point of onset can be the difference in a more positive outcome. If suffering from an ischemic or hemorrhagic stroke, the goal is to get to a hospital with a stroke center that will be able to give the best treatment possible. Our NeuroHawk EMS device is positioned to support the EMT decision-making process.

Chief Commercial Officer Eric Bailey, with four decades of experience improving medical imaging devices, says getting the right treatment in that short time could be the difference between life and death if you’re taken to the wrong hospital.

“It’s going to be a waste of time and to get out of that hospital. It could take you hours and by then your brain injury could either have killed you or you’re severely injured,” Bailey adds. “Brain doesn’t regrow. That’s the other thing here, is that you lose it. It’s gone.”

We designed NeuroHawk EMS to have a small footprint that easily fits in an ambulance. It’s also simple to use and gives results in minutes. That way, if EMTs detect a TBI, then they can go to a trauma center. But if they detect a stroke, they can redirect to a hospital with a stroke center to ensure the best care possible.

About 468,000 service members have been diagnosed with a TBI since 2000 due to blasts or injuries in combat or during training. But most of the time these are not getting diagnosed until the service member is at home or on base.

Bailey, a veteran and graduate of the Citadel, knows the difference this device can make. He says, “I lost my roommate to Desert Storm. He was the only kid out of the Citadel that died in Desert Storm. And I like to think that maybe he’d be alive today if he had this device was in the battlefield.”

NeuroHawk Military is small, portable, and accurate so people on the front line can get the answer they need in real time so they know whether that service member needs to be transported out of the field or not.

The Future of Sense Neuro
We’re now on our way to FDA clearance and can’t wait to bring this technology to a field that desperately needs objective detection and monitoring of stroke and TBI, which when left untreated or improperly treated has a $300 billion impact on the U.S. healthcare system each year. NeuSTAT, NeuroHawk EMT, and NeuroHawk Military are the solution that can lead to better outcomes for patients and neurological deficits.

Behind the Science: Non-Invasive Brain Scanners

Time is brain. You’ll hear us say that a lot at Sense Neuro Diagnostics. We’re on a mission to aid personnel to detect, monitor, and manage brain conditions in real-time. Once a brain cell dies, there’s no getting it back. If you or a loved one is riding in an ambulance going to a hospital ill-prepared for a brain injury or waiting in the ER for a CT scan, those could be crucial moments slipping away that you’ll never get back, possibly resulting in permanent disability or death.

Sense Neuro Welcomes Eric Bailey as Chief Commercial Officer

Cincinnati, OH - Sense Neuro Diagnostics today announced the hiring of Eric Bailey as Chief Commercial Officer. With experience as a seasoned CEO and expertise in technical and operational responsibilities in startup businesses, specifically in the market areas Sense Neuro intends to enter, we are proud to welcome Bailey to the team.

US FDA New Clinical for Sense Neuro Diagnostics

The new trial approved by the FDA Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices will begin as soon as June 2023 and involve up to 300 patients at 30 sites in the United States, as well as Canada and India.

St. Elizabeth Healthcare Invests $250,000 In Sense Neuro Diagnostics

Medical technology startup Sense Neuro Diagnostics has received $250,000 in funding from St. Elizabeth Healthcare in Edgewood, Kentucky. The investment will help Sense Neuro Diagnostics as the company advances clinical trials in its effort to commercialize a non-invasive technology to monitor traumatic brain injuries.

Sense Neuro Diagnostics Places Second In Unicorn Cup Finals Q4 2022

Cincinnati-based Sense Neuro Diagnostics is pursuing new international investment opportunities after coming in second place in the Unicorn CUP Finals startup competition. The pitch event is affiliated with Unicorn Events, the world’s largest startup pitch competition that focuses on discovering extraordinary startups that have the potential to achieve a valuation of $1 billion or more.